Wells Fargo & Company »

Phio Pharmaceuticals shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Phio Pharmaceuticals (PHIO) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Phio Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phio Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phio Pharmaceuticals by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $13 19 0.74
2023-09-30 $24 16 1.50
2023-06-30 $32 11 2.91

More positions owned by Wells Fargo & Company

Microsoft Corporation Put Option (MSFT)
Apple (AAPL)
Ishares Tr Russell 2000 Etf (IWM)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Amazon Put Option (AMZN)
Vanguard Index Fds Mid Cap Etf Put Option (VO)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core S&p Ttl Stk (ITOT)
UnitedHealth Call Option (UNH)
JPMorgan Chase & Co. Put Option (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Johnson & Johnson (JNJ)

View all positions for Wells Fargo & Company

Top funds holding Phio Pharmaceuticals

Citadel Advisors
Vanguard Group
Bank Of Montreal
Virtu Financial
Cambridge Investment Research Advisors
Wells Fargo & Company

View all funds holding Phio Pharmaceuticals